Bryon H. Short
- Democratic
Primary
This legislation creates a benchmark for determining when a treatment or service is no longer experimental or investigational. When Medicare determines that a treatment is safe for its population, commercial insurers in Delaware may no longer deny coverage on that basis. This bill will remove inconsistencies for properly-evidenced treatments between payers.
Signed by Governor
Passed By Senate. Votes: 20 YES 1 ABSENT
Reported Out of Committee (Banking, Business & Insurance) in Senate with 1 Favorable, 3 On Its Merits
Assigned to Banking, Business & Insurance Committee in Senate
Passed By House. Votes: 41 YES
Amendment HA 1 to HS 1 - Passed In House by Voice Vote
Reported Out of Committee (Economic Development/Banking/Insurance/Commerce) in House with 7 On Its Merits
Amendment HA 1 to HS 1 - Introduced and Placed With Bill
was introduced and adopted in lieu of HB 319
Assigned to Economic Development/Banking/Insurance/Commerce Committee in House
| Bill Text Versions | Format |
|---|---|
| Bill Text | HTML PDF |
| Document | Format |
|---|---|
| No related documents. |
Data on Open States is updated periodically throughout the day from the official website of the Delaware General Assembly.
If you notice any inconsistencies with these official sources, feel free to file an issue.